BRIEF- Sichuan Kelun Pharmaceutical issue 500 mln yuan financing notes
Europe ready to embrace first copies of biotech cancer drugs
LONDON, Feb 15 Treatment with two important cancer drugs is about to get much cheaper in Europe with a cut-price copy of Roche's blood cancer drug Rituxan likely to hit the market imminently followed by a rival to its breast cancer medicine Herceptin.